Impact of NPSR1 gene variation on the neural correlates of phasic and sustained fear in spider phobia - an imaging genetics and independent replication approach.
NPSR1
imaging genetics
phasic fear
sustained fear
Journal
Social cognitive and affective neuroscience
ISSN: 1749-5024
Titre abrégé: Soc Cogn Affect Neurosci
Pays: England
ID NLM: 101288795
Informations de publication
Date de publication:
21 Aug 2024
21 Aug 2024
Historique:
received:
21
10
2023
revised:
13
05
2024
accepted:
19
08
2024
medline:
21
8
2024
pubmed:
21
8
2024
entrez:
21
8
2024
Statut:
aheadofprint
Résumé
The functional neuropeptide S receptor 1 (NPSR1) gene A/T variant (rs324981) is associated with fear processing. We investigated the impact of NPSR1 genotype on fear processing and on symptom reduction following treatment in individuals with spider phobia. A replication approach was applied (discovery sample: Münster (MS) nMS=104; replication sample Würzburg (WZ) nWZ=81). Participants were genotyped for NPSR1 rs324981 (T-allele carriers [risk] versus AA homozygotes [no-risk]). A sustained and phasic fear paradigm was applied during functional magnetic resonance imaging. A one-session virtual reality exposure treatment (VRET) was conducted. Change of symptom severity from pre to post treatment and within session fear reduction were assessed. T-allele carriers in the discovery sample displayed lower anterior cingulate cortex (ACC) activation compared to AA homozygotes independent of condition. For sustained fear, this effect was replicated within a small cluster and medium effect size. No association with symptom reduction was found. Within-session fear reduction was negatively associated with ACC activation in T-allele carriers in the discovery sample. NPSR1 rs324981 genotype might be associated with fear processing in the ACC in spider phobia. Interpretation as potential risk-increasing function of the NPSR1 rs324981 T-allele via impaired top-down control of limbic structures remains speculative. Potential association with symptom reduction warrants further research.
Identifiants
pubmed: 39167471
pii: 7738138
doi: 10.1093/scan/nsae054
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : "Innovative Medizinische Forschung" (IMF) of the Medical Faculty, University of Münster
ID : LE121703 and LE121904
Organisme : Deutsche Forschungsgemeinschaft
ID : 44541416-TRR 58
Organisme : Interdisciplinary Center for Clinical Research (IZKF) of the medical faculty of Münster
ID : Dan3/012/17
Informations de copyright
© The Author(s) 2024. Published by Oxford University Press.